Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, agosto 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
NeoGenomics Inc
NEO
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$18.64
1.27
7.31%
In chiusura: Aug 26, 5:00 PM EST
$19.00
1.63
9.38%
Pre-mercato: 7:00 AM EST
Get Report
PRO
Perché si muove?:
NeoGenomics shares are trading higher after the company announced that its ...
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
NeoGenomics Financials
NeoGenomics (NEO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
NeoGenomics Raises FY2026 Sales Guidance from $797.000M-$803.000M to $802.000M-$806.000M vs $800.433M Est
NeoGenomics (NASDAQ:NEO) raises FY2026 sales outlook from $797.000 million-$803.000 million to $802.000 million-$806.000 million vs $800.433 million estimate.
Benzinga Newsdesk
PRO
NeoGenomics Q2 Adj. EPS $0.05 Beats $0.03 Estimate, Sales $202.000M Beat $196.997M Estimate
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 66.67 percent increase over earnings of $0.03 per share from the
Benzinga Newsdesk
Earnings Scheduled For May 12, 2026
Benzinga Insights
PRO
NeoGenomics Raises FY2026 Sales Guidance from $793.000M-$801.000M to $797.000M-$803.000M vs $796.641M Est
NeoGenomics (NASDAQ:NEO) raises FY2026 sales outlook from $793.000 million-$801.000 million to $797.000 million-$803.000 million vs $796.641 million estimate.
Benzinga Newsdesk
PRO
NeoGenomics Q1 Adj. EPS $0.01, Inline, Sales $186.672M Beat $184.509M Estimate
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. The company reported quarterly sales of $186.672 million which beat the analyst consensus estimate of
Benzinga Newsdesk
Earnings Scheduled For April 28, 2026
Benzinga Insights
Privacy Manager